CN Stock MarketDetailed Quotes
300676 BGI Genomics
- 48.19
- +0.25+0.52%
Trading Nov 8 09:31 CST
20.04BMarket Cap-197500P/E (TTM)
48.88High48.16Low4.55KlotVolume48.30Open47.94Pre Close22.10MTurnover0.11%Turnover Ratio216.10P/E (Static)415.82MShares56.8952wk High2.04P/B19.88BFloat Cap32.9052wk Low57.53Limit Up412.52MShs Float259.49Historical High38.35Limit Down1.50%Amplitude13.87Historical Low0.10Dividend TTM48.52Avg Price3.37KlotAsk0.21%Div YieldTTM100Lot Size1.06KlotBid
BGI Genomics Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -10.10%2.83B | -9.67%1.87B | -14.00%821.25M | -38.33%4.35B | -30.42%3.14B | -34.46%2.07B | -33.23%954.89M | 4.24%7.05B | -12.32%4.52B | -13.30%3.16B |
| Operating revenue | -10.10%2.83B | -9.67%1.87B | -14.00%821.25M | -38.33%4.35B | -30.42%3.14B | -34.46%2.07B | -33.23%954.89M | 4.24%7.05B | -12.32%4.52B | -13.30%3.16B |
| Other operating revenue | ---- | -36.13%10.78M | ---- | 1.42%16.91M | ---- | 82.53%16.87M | ---- | 41.94%16.67M | ---- | 25.82%9.24M |
| Total operating cost | -6.52%2.82B | -10.92%1.79B | -17.51%786.45M | -30.27%4.11B | -18.79%3.02B | -20.26%2.01B | -8.06%953.39M | 16.13%5.9B | 3.57%3.72B | 4.16%2.52B |
| Operating cost | -4.76%1.55B | -11.84%987.55M | -20.41%417.23M | -35.27%2.18B | -20.31%1.63B | -22.83%1.12B | -11.68%524.24M | 18.72%3.37B | -2.09%2.04B | 2.28%1.45B |
| Operating tax surcharges | 66.01%12.76M | 48.46%8.32M | 14.98%3.48M | 5.07%13.75M | -7.01%7.69M | -4.14%5.6M | -3.28%3.03M | -46.29%13.08M | -51.72%8.27M | -33.57%5.84M |
| Operating expense | -12.39%663.33M | -14.13%398.28M | -24.22%169.89M | -35.53%1.04B | -23.77%757.1M | -24.74%463.82M | -1.15%224.19M | 29.80%1.61B | 20.60%993.23M | 9.52%616.28M |
| Administration expense | -2.17%257.38M | -0.99%169.89M | 12.03%99.67M | 4.64%398.82M | -1.55%263.1M | -2.21%171.58M | 16.20%88.97M | -1.44%381.12M | 11.10%267.23M | 16.57%175.45M |
| Financial expense | -141.59%-59.12M | -39.05%-26.96M | -12.23%-10.2M | -444.87%-45.88M | -278.99%-24.47M | -374.85%-19.39M | -262.44%-9.09M | -108.08%-8.42M | -79.86%13.67M | -88.74%7.05M |
| -Interest expense (Financial expense) | -28.27%43.22M | -15.73%33.39M | -9.17%18.29M | -9.13%91.56M | -22.88%60.26M | -32.23%39.63M | -14.64%20.13M | -3.77%100.76M | -0.52%78.13M | 9.00%58.47M |
| -Interest Income (Financial expense) | 0.50%-100.28M | -18.89%-73.54M | -24.09%-35.56M | -30.08%-152.04M | -19.96%-100.79M | -11.40%-61.85M | -33.83%-28.65M | -163.58%-116.88M | -193.87%-84.02M | -188.22%-55.52M |
| Research and development | 2.50%398.01M | -5.42%250.25M | -12.85%106.37M | -1.28%528.92M | -1.20%388.31M | 1.83%264.58M | -7.10%122.05M | 9.98%535.78M | 10.74%393.03M | 22.74%259.84M |
| Credit Impairment Loss | -567.63%-105.49M | -1,330.87%-58.18M | -221.92%-24.18M | 71.24%-69.61M | 87.54%-15.8M | 106.35%4.73M | 172.47%19.83M | -131.68%-242.05M | -54.67%-126.76M | 16.34%-74.44M |
| Asset Impairment Loss | 64.18%-6.43M | 87.10%-2.5M | 20.96%-2.07M | 91.63%-26.66M | -292.42%-17.94M | -609.73%-19.38M | 13.35%-2.62M | -339.89%-318.46M | -247.28%-4.57M | -192.18%-2.73M |
| Other net revenue | -541.50%-125.1M | -1,926.97%-55.71M | -132.03%-15.91M | -25.62%-88.06M | -124.09%-19.5M | -95.72%3.05M | 8,420.39%49.67M | -152.75%-70.1M | -34.50%80.95M | 9.25%71.28M |
| Fair value change income | 69.28%-13.67M | 80.21%-7.11M | 70.70%-4.72M | -142.56%-34.36M | -271.83%-44.5M | -377.87%-35.92M | -317.91%-16.11M | -6.57%80.73M | -61.39%25.9M | -67.68%12.93M |
| Invest income | -171.72%-21.85M | -137.27%-11.09M | -103.83%-1.25M | -99.58%1.28M | -76.19%30.46M | -68.33%29.75M | 359.87%32.55M | 76.90%307.48M | 11.73%127.93M | -0.75%93.94M |
| -Including: Investment income associates | -861.58%-44.1M | -445.16%-21.44M | -154.13%-6.8M | -110.59%-31.54M | -103.92%-4.59M | -92.75%6.21M | 1,073.94%12.56M | 166.74%297.91M | 48.06%117.14M | 14.63%85.69M |
| Asset deal income | -41.45%773.03K | 44.33%2.69M | -28.37%1.52M | 2,513.65%2.76M | -30.57%1.32M | 171.38%1.86M | 15,352.39%2.13M | 102.72%105.75K | 153.73%1.9M | 118.92%685.6K |
| Other revenue | -20.03%21.56M | -6.92%20.48M | 6.46%14.78M | -62.26%38.52M | -52.32%26.97M | -46.20%22.01M | -9.46%13.89M | 91.09%102.08M | 131.78%56.56M | 102.05%40.91M |
| Operating profit | -212.14%-119.7M | -58.51%28.43M | -63.07%18.89M | -86.15%150.65M | -87.91%106.74M | -90.44%68.52M | -86.97%51.16M | -40.32%1.09B | -47.69%883.15M | -44.70%716.6M |
| Add:Non operating Income | -4.27%1.59M | 44.97%1.28M | -42.02%57.37K | 266.81%1.8M | 268.58%1.66M | 1,348.34%880.04K | 871.29%98.95K | -87.66%491.56K | -64.88%451.29K | -94.89%60.76K |
| Less:Non operating expense | -58.66%8.92M | -35.10%4.37M | 22.77%2.91M | -54.76%36.92M | 87.85%21.57M | 163.20%6.73M | 122.37%2.37M | 0.85%81.61M | -39.21%11.48M | -86.26%2.56M |
| Total profit | -246.27%-127.02M | -59.58%25.33M | -67.19%16.04M | -88.52%115.54M | -90.04%86.84M | -91.22%62.67M | -87.51%48.89M | -42.33%1.01B | -47.80%872.13M | -44.14%714.1M |
| Less:Income tax cost | -117.03%-2.84M | -59.22%5.18M | -49.42%3.89M | -88.94%21.85M | -86.71%16.69M | -88.30%12.71M | -87.11%7.69M | -26.36%197.51M | -47.54%125.65M | -41.05%108.6M |
| Net profit | SL-124.18M | -59.66%20.15M | -70.51%12.15M | -88.42%93.68M | -90.60%70.15M | -91.75%49.96M | -87.58%41.2M | -45.23%809.29M | -47.84%746.48M | -44.66%605.5M |
| Net profit from continuing operation | -277.03%-124.18M | -59.66%20.15M | -70.51%12.15M | -88.42%93.68M | -90.60%70.15M | -91.75%49.96M | -87.58%41.2M | -45.23%809.29M | -47.84%746.48M | -44.66%605.5M |
| Less:Minority Profit | 93.05%-14.29K | 1,013.46%1.95M | -2,078.15%-252.26K | -88.01%781.45K | 66.76%-205.71K | 144.42%175.44K | -100.81%-11.58K | -59.66%6.52M | -103.66%-618.88K | -104.84%-394.97K |
| Net profit of parent company owners | -276.49%-124.17M | -63.45%18.2M | -69.91%12.4M | -88.43%92.9M | -90.58%70.35M | -91.78%49.79M | -87.53%41.21M | -45.07%802.77M | -47.17%747.1M | -44.21%605.9M |
| Earning per share | ||||||||||
| Basic earning per share | -278.91%-0.3011 | -64.36%0.0433 | -66.63%0.0303 | -88.42%0.2266 | -90.79%0.1683 | -91.79%0.1215 | -88.72%0.0908 | -45.12%1.9562 | -47.17%1.8273 | -44.32%1.4806 |
| Diluted earning per share | -278.89%-0.3009 | -63.64%0.0441 | -69.95%0.0302 | -88.54%0.2253 | -90.79%0.1682 | -91.81%0.1213 | -87.49%0.1005 | -44.63%1.9657 | -46.89%1.827 | -44.05%1.4803 |
| Other composite income | -126.34%-30.13M | -89.88%14.38M | 82.93%-12.11M | -108.99%-29.98M | -67.62%114.36M | -2.72%142.11M | -216.09%-70.93M | 597.81%333.33M | 2,456.62%353.2M | 1,501.80%146.08M |
| Other composite income of parent company owners | -125.38%-28.84M | -89.29%15.14M | 84.05%-11.1M | -108.84%-28.89M | -67.14%113.62M | -0.87%141.42M | -214.16%-69.59M | 595.97%326.66M | 2,234.73%345.74M | 1,299.65%142.65M |
| Other composite income of minority owners | -272.61%-1.28M | -208.61%-755.96K | 24.87%-1.01M | -116.32%-1.09M | -90.02%744.37K | -79.71%696.04K | -363.71%-1.35M | 708.39%6.67M | 850.85%7.46M | 419.99%3.43M |
| Total composite income | -183.63%-154.31M | -82.02%34.54M | 100.13%39.04K | -94.42%63.71M | -83.22%184.51M | -74.44%192.08M | -109.61%-29.73M | -19.01%1.14B | -23.90%1.1B | -31.88%751.59M |
| Total composite income of parent company owners | -183.17%-153.01M | -82.56%33.34M | 104.59%1.3M | -94.33%64.01M | -83.17%183.97M | -74.46%191.21M | -109.20%-28.37M | -19.08%1.13B | -23.53%1.09B | -31.71%748.55M |
| Total composite income of minority owners | -341.18%-1.3M | 37.41%1.2M | 6.93%-1.26M | -102.33%-306.94K | -92.13%538.66K | -71.29%871.48K | -219.83%-1.36M | -12.46%13.19M | -57.04%6.84M | -57.21%3.04M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data